Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.

After being absorbed, drugs distribute in the body in part to reach target tissues, in part to be disposed in tissues where they do not exert clinically-relevant effects. Therapeutically-relevant effects are usually terminated by drug metabolism and/or elimination. The role that has been traditionally ascribed to the spleen in these fundamental pharmacokinetic processes was definitely marginal. However, due to its high blood flow and to the characteristics of its microcirculation, this organ would be expected to be significantly exposed to large, new generation drugs that can hardly penetrate in other tissues with tight endothelial barriers. In the present review, we examine the involvement of the spleen in the disposition of monoclonal antibodies, nanoparticles and exosomes and the possible implications for their therapeutic efficacy and toxicity. The data that we will review lead to the conclusion that a new role is emerging for the spleen in the pharmacokinetics of new generation drugs, hence suggesting that this small, neglected organ will certainly deserve stronger attention by pharmacologists in the future.

The evolving concept of the intrinsic hippocampal theta/gamma oscillator.

Three main types of electrical oscillations are recorded from the hippocampus in vivo: theta (θ), gamma (γ) and sharp wave ripples with frequency bands of 4-12, 25-100 and 110-250 Hz, respectively. Theta activity is the more robust of them, and has important physiological roles because it is involved in spatial navigation, memory formation and memory retrieval. Classical lesion studies in vivo have suggested that the hippocampus passively follows the θ  rhythm generated in the septum by neurons that are synaptically connected with hippocampal neurons though septo-hippocampal connections. This view has been questioned since several studies have shown that oscillations in the θ range can be recorded in in vitro hippocampal preparations thus indicating that the hippocampus itself can act as a θ oscillator. In this review, we will describe how the paradigm of the intrinsic θ oscillator has been changing over the years from simple models that have proposed single hippocampal lamellae to contain the θ oscillator to the current models that include some degree of septo-temporal integration.